Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Feb 1, 2017 at 10:05 AM EST

Why Investors Cheered Anthem Earnings

Anthem released a better-than-expected earnings report before the markets opened on Wednesday, pushing shares to a new high.

Paul Ausick | Jan 31, 2017 at 10:55 AM EST

Obamacare Repeal Cost: 1.2 Million Jobs Nationwide

Repealing Obamacare could cost up to 1.2 million U.S. jobs, and that is not a price that opponents are willing…

Lee Jackson | Jan 31, 2017 at 10:15 AM EST

4 Top Biotech Stocks With Big Upcoming Catalysts

In a new report, SunTrust Robinson Humphrey analysts are focused on upcoming catalysts for biotech stocks in their coverage universe.

Chris Lange | Jan 31, 2017 at 9:50 AM EST

How Eli Lilly Earnings Won Big on New Drug Sales

Eli Lilly released a mixed fourth-quarter earnings report and offered full-year guidance before the markets opened on Tuesday.

Chris Lange | Jan 31, 2017 at 8:55 AM EST

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

When Pfizer reported its fourth-quarter financial results before the markets opened on Tuesday, earnings fell short of consensus estimates.

Chris Lange | Jan 30, 2017 at 3:39 PM EST

Is This the Beginning of EyeGate’s Rally?

Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) saw its shares rise handily on Monday following positive top-line results from the company’s first-in-human…

Chris Lange | Jan 30, 2017 at 12:55 PM EST

Why the Rigel Pharmaceuticals Update Could Signal Further Growth

Rigel Pharmaceuticals shares saw a solid gain to kick off the week after the company gave an update on one…

Chris Lange | Jan 30, 2017 at 10:50 AM EST

Why This Collaboration Is So Important for Calithera

Shares of Calithera Biosciences saw a solid gain early on Monday after the company reported a global collaboration and licensing…

Chris Lange | Jan 30, 2017 at 8:55 AM EST

Why the Pulmatrix Pullback Makes Sense

Pulmatrix saw its shares take a sharp downturn on Monday morning after the company announced that it had entered into…

Chris Lange | Jan 28, 2017 at 9:45 AM EST

Is This the Formal Implosion of Novan?

Novan saw its shares get absolutely crushed on Friday after the company reported results from its late-stage treatment of acne…

Chris Lange | Jan 27, 2017 at 8:45 AM EST

AbbVie Slides on Mixed Q4 Earnings

AbbVie reported mixed fourth-quarter financial results and offered guidance before the markets opened on Friday.

Chris Lange | Jan 26, 2017 at 10:35 AM EST

Short Sellers Back Off Major Biotechs

As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears…

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 25, 2017 at 11:25 AM EST

What to Expect From Major Health Care Stocks Reporting This Week

The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already…

Chris Lange | Jan 24, 2017 at 3:13 PM EST

Ocular Therapeutics Sinks Following Secondary Offering

Ocular Therapeutix, Inc. (NASDAQ: OCUL) saw its shares take a dive on Tuesday after the company announced the pricing of…

1 … 175 176 177 178 179 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why Investors Cheered Anthem Earnings

Obamacare Repeal Cost: 1.2 Million Jobs Nationwide

4 Top Biotech Stocks With Big Upcoming Catalysts

How Eli Lilly Earnings Won Big on New Drug Sales

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

Is This the Beginning of EyeGate’s Rally?

Why the Rigel Pharmaceuticals Update Could Signal Further Growth

Why This Collaboration Is So Important for Calithera

Why the Pulmatrix Pullback Makes Sense

Is This the Formal Implosion of Novan?

AbbVie Slides on Mixed Q4 Earnings

Short Sellers Back Off Major Biotechs

Short Sellers Run for Cover From Major Pharma

What to Expect From Major Health Care Stocks Reporting This Week

Ocular Therapeutics Sinks Following Secondary Offering

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Why Investors Cheered Anthem Earnings

Obamacare Repeal Cost: 1.2 Million Jobs Nationwide

4 Top Biotech Stocks With Big Upcoming Catalysts

How Eli Lilly Earnings Won Big on New Drug Sales

Are Pfizer’s Acquisitions Holding Back Its Bottom Line?

Is This the Beginning of EyeGate’s Rally?

Why the Rigel Pharmaceuticals Update Could Signal Further Growth

Why This Collaboration Is So Important for Calithera

Why the Pulmatrix Pullback Makes Sense

Is This the Formal Implosion of Novan?

AbbVie Slides on Mixed Q4 Earnings

Short Sellers Back Off Major Biotechs

Short Sellers Run for Cover From Major Pharma

What to Expect From Major Health Care Stocks Reporting This Week

Ocular Therapeutics Sinks Following Secondary Offering

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check